You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Version1.0
Creation Date2019-07-14 16:37:12 UTC
Last Updated2019-10-01 21:41:34 UTC
CypComp IDCC02165
Compound Information
NameV11294
Structure ImageCgfrgbqjwvftrf uhfffaoysa n
InChIKeyCGFRGBQJWVFTRF-UHFFFAOYSA-N
PubChem IDNot Available
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • <21,H;Hydroxylation;R1>
  • <22,H;Hydroxylation;R2>
  • <25,H;Hydroxylation;R3>
  • <29,28;Cleavage;R4>
  • <29,H;Oxidation;R4>
  • <29,28;Cleavage;R1>
  • <29,H;Oxidation;R1>
  • <29,28;Cleavage;R1>
  • <29,H;Oxidation;R1>
  • Not Available
  • <21,H;Hydroxylation;R1>
  • <22,H;Hydroxylation;R2>
  • <25,H;Hydroxylation;R3>
  • <29,28;Cleavage;R4>
  • <29,H;Oxidation;R4>
References
  1. Subrahmanyam V, Renwick AB, Walters DG, Price RJ, Tonelli AP, Lake BG: Metabolism of a novel phosphodiesterase-IV inhibitor (V11294) by human hepatic cytochrome P450 forms. Xenobiotica. 2002 Jun;32(6):521-34. doi: 10.1080/00498250210128684. [PubMed:12160484 ]
Download FileCC02165.sdf